ONA Therapeutics
A graduate of EDHEC Business School, Mr. Morin began his career in 2005 at MAZARS, as a Financial Auditor for Private Equity Firms. In 2009, he joined CDC Enterprises, a Funds Management company, as Financial Manager where he was involved in structuring several investment funds and for the portfolio monitoring, mostly in Venture Capital. In September 2013, Mr. Morin joined the Life Sciences investment activities. He is now an Investment Director dedicated mostly to creating and developing biotechnology start-ups
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ONA Therapeutics
Ona Therapeutics is a biotech company, spin-off of ICREA and IRB, specialized in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism.